Suven Life Sciences Ltd

Suven Life Sciences Ltd

₹ 100 0.05%
28 Mar - close price
About

Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.[1]

Key Points

Primary Focus
The company has been working towards developing new molecules/ compounds in the complex CNS (central nervous system) space. [1]
Most of its lead molecules address the niche areas of cognitive impairments such as amnesia, dementia, narcolepsy, Alzheimer's, delirium, etc. [2]
CNS is the 2nd largest therapeutic category in the pharmaceutical industry and is also one of the fastest growing segments. [3]

  • Market Cap 2,193 Cr.
  • Current Price 100
  • High / Low 129 / 47.2
  • Stock P/E
  • Book Value 39.1
  • Dividend Yield 0.00 %
  • ROCE -4.11 %
  • ROE -4.20 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Debtor days have improved from 36.5 to 21.8 days.

Cons

  • Stock is trading at 2.56 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -53.5% over past five years.
  • Company has a low return on equity of -6.22% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1.51 1.56 2.01 1.18 4.43 4.22 3.54 4.39 3.00 2.61 3.80 3.06 2.45
11.90 10.10 13.88 11.48 11.44 11.69 10.61 11.84 10.10 8.74 10.60 11.14 11.65
Operating Profit -10.39 -8.54 -11.87 -10.30 -7.01 -7.47 -7.07 -7.45 -7.10 -6.13 -6.80 -8.08 -9.20
OPM % -688.08% -547.44% -590.55% -872.88% -158.24% -177.01% -199.72% -169.70% -236.67% -234.87% -178.95% -264.05% -375.51%
1.62 1.32 4.56 0.50 0.14 0.12 6.44 0.21 2.20 5.60 5.64 12.60 6.07
Interest 0.14 0.18 0.15 0.15 0.13 0.10 0.10 0.07 0.06 0.05 0.05 0.04 0.04
Depreciation 1.14 1.07 1.03 1.03 1.22 1.10 1.58 1.62 1.67 1.67 1.66 1.73 1.60
Profit before tax -10.05 -8.47 -8.49 -10.98 -8.22 -8.55 -2.31 -8.93 -6.63 -2.25 -2.87 2.75 -4.77
Tax % 19.00% -0.59% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
-8.15 -8.51 -8.49 -10.98 -8.22 -8.55 -2.31 -8.93 -6.63 -2.25 -2.87 2.76 -4.77
EPS in Rs -0.43 -0.45 -0.44 -0.58 -0.43 -0.39 -0.11 -0.41 -0.30 -0.10 -0.13 0.13 -0.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
204.14 257.74 510.29 520.86 499.27 543.23 625.20 285.67 12.62 13.48 11.84 13.54 11.92
180.98 204.55 291.23 361.40 369.38 377.88 392.28 236.98 47.89 43.93 48.30 41.05 42.13
Operating Profit 23.16 53.19 219.06 159.46 129.89 165.35 232.92 48.69 -35.27 -30.45 -36.46 -27.51 -30.21
OPM % 11.35% 20.64% 42.93% 30.61% 26.02% 30.44% 37.26% 17.04% -279.48% -225.89% -307.94% -203.18% -253.44%
1.89 1.04 3.03 8.58 19.29 21.09 23.27 27.25 14.04 7.75 5.24 14.45 29.91
Interest 9.91 13.51 10.51 4.71 5.87 5.67 4.61 1.90 0.54 0.91 0.64 0.52 0.18
Depreciation 6.00 7.87 8.84 11.78 17.50 21.41 21.31 10.79 4.17 4.35 4.39 6.54 6.66
Profit before tax 9.14 32.85 202.74 151.55 125.81 159.36 230.27 63.25 -25.94 -27.96 -36.25 -20.12 -7.14
Tax % -57.11% 6.12% 28.89% 28.25% 20.45% 22.52% 31.20% 38.04% 46.95% 19.03% -0.00% -0.00%
14.36 30.84 144.16 108.75 100.08 123.47 158.43 39.19 -13.75 -22.63 -36.25 -20.13 -7.13
EPS in Rs 0.82 1.76 8.23 5.70 5.24 6.47 8.30 2.05 -0.72 -1.19 -1.66 -0.92 -0.32
Dividend Payout % 24.38% 11.36% 20.26% 7.02% 25.44% 10.31% 12.05% 48.72% -0.00% -0.00% -0.00% -0.00%
Compounded Sales Growth
10 Years: -26%
5 Years: -54%
3 Years: 2%
TTM: -21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -66%
TTM: 55%
Stock Price CAGR
10 Years: 36%
5 Years: 43%
3 Years: 15%
1 Year: 113%
Return on Equity
10 Years: 10%
5 Years: -3%
3 Years: -6%
Last Year: -4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 11.67 11.68 11.68 12.73 12.73 12.73 12.73 12.73 12.73 12.73 14.54 21.81 21.81
Reserves 115.85 142.78 252.76 546.59 610.74 718.80 853.97 388.99 374.95 352.01 461.44 831.64 831.62
97.80 117.07 90.57 108.51 82.55 70.79 33.99 2.72 6.01 4.76 3.21 1.61 1.17
59.66 56.09 131.62 105.30 67.75 73.85 113.79 35.04 16.07 45.88 7.17 5.38 7.94
Total Liabilities 284.98 327.62 486.63 773.13 773.77 876.17 1,014.48 439.48 409.76 415.38 486.36 860.44 862.54
132.44 161.52 179.23 171.95 305.35 305.72 307.73 22.35 24.69 20.96 37.56 37.21 34.19
CWIP 23.64 4.15 12.82 107.01 7.20 9.72 24.74 0.02 -0.00 4.77 3.55 -0.00 -0.00
Investments 4.52 0.07 0.04 0.04 23.10 365.97 381.02 359.29 241.86 295.11 425.85 528.20 591.69
124.38 161.88 294.54 494.13 438.12 194.76 300.99 57.82 143.21 94.54 19.40 295.03 236.66
Total Assets 284.98 327.62 486.63 773.13 773.77 876.17 1,014.48 439.48 409.76 415.38 486.36 860.44 862.54

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
33.75 30.69 121.18 142.91 89.82 147.27 104.77 -12.01 -45.15 -36.68 -36.62 -10.09
-31.99 -14.66 -35.53 -110.45 -61.65 -352.61 -37.81 -3.52 42.03 2.41 -107.46 -361.66
-1.83 2.55 -38.23 179.13 -68.06 -30.37 -52.05 4.55 3.81 34.86 145.69 395.54
Net Cash Flow -0.07 18.58 47.42 211.59 -39.90 -235.71 14.92 -10.98 0.69 0.58 1.61 23.79

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 45.13 33.68 46.83 28.15 39.16 30.79 35.93 3.37 65.65 47.66 40.08 21.84
Inventory Days 223.88 237.58 210.23 165.22 183.07 222.37 328.51 -0.00
Days Payable 120.90 159.56 109.35 88.64 78.09 91.20 133.84
Cash Conversion Cycle 148.11 111.69 147.70 104.73 144.14 161.96 230.61 3.37 65.65 47.66 40.08 21.84
Working Capital Days 34.60 50.13 61.51 68.74 77.24 65.60 102.52 56.33 1,210.98 1,320.28 331.09 470.40
ROCE % 9.12% 18.66% 68.07% 30.53% 16.85% 19.22% 25.45% 6.80% -6.49% -7.10% -9.33% -4.11%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
60.00% 60.00% 60.00% 60.00% 64.98% 64.98% 64.98% 69.56% 69.56% 69.56% 69.56% 69.56%
0.48% 0.41% 0.44% 0.52% 0.45% 0.45% 0.48% 0.46% 0.51% 0.48% 0.50% 0.54%
0.66% 0.44% 0.44% 0.44% 0.46% 0.39% 0.12% 0.11% 0.11% 0.08% 0.01% 0.01%
38.86% 39.15% 39.12% 39.04% 34.11% 34.18% 34.41% 29.85% 29.80% 29.88% 29.92% 29.88%
No. of Shareholders 77,65086,00881,47580,19581,03981,03880,11680,83878,63476,29180,95374,003

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls